These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7490678)

  • 21. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.
    Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR
    Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis.
    Koreth J; Bethwaite PB; McGee JO
    J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of p53 gene in primary gastric cancer tissues.
    Hong SI; Hong WS; Jang JJ; Lee DS; Cho NS; Jung ME; Kim HB; Ha GW; Park IC; Cho DS
    Anticancer Res; 1994; 14(3B):1251-5. PubMed ID: 8067692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular analysis of the estrogen receptor (ER) gene in association with ER negativity in breast cancer].
    Iwase H; Kobayashi S; Iwata H; Yamashita T; Ito K; Toyama T; Hara Y; Greenman J; Mathew CG
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():61-5. PubMed ID: 8702313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques.
    Hurlimann J; Chaubert P; Benhattar J
    Mod Pathol; 1994 May; 7(4):423-8. PubMed ID: 8066070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
    Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [PCR-SSCP and sequencing analysis on mutations of anti-oncogene p53 in asbestos-related lung cancer].
    Fu D; Liu B; Miao Q; Wang H
    Wei Sheng Yan Jiu; 1997 Sep; 26(5):289-92. PubMed ID: 10325638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.
    Jeffers MD; Farquharson MA; Richmond JA; McNicol AM
    J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of point mutation of p53 gene in head and neck squamous cell carcinoma by non-isotopic PCR-SSCP].
    Wang J; Huang H; Li J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 Aug; 15(3):215-7. PubMed ID: 11480000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of loss of heterozygosity in the p53 tumor suppressor gene using a PCR-based assay.
    Ridanpää M; Anttila S; Husgafvel-Pursiainen K
    Pathol Res Pract; 1995 Jun; 191(5):399-402. PubMed ID: 7479357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.
    Sundaresan V; Ganly P; Hasleton P; Rudd R; Sinha G; Bleehen NM; Rabbitts P
    Oncogene; 1992 Oct; 7(10):1989-97. PubMed ID: 1408139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometry-based loss of heterozygosity analysis of single-nucleotide polymorphism loci in paraffin embedded tumors using the MassEXTEND assay: single-nucleotide polymorphism loss of heterozygosity analysis of the protein tyrosine phosphatase receptor type J in familial colorectal cancer.
    van Puijenbroek M; Dierssen JW; Stanssens P; van Eijk R; Cleton-Jansen AM; van Wezel T; Morreau H
    J Mol Diagn; 2005 Nov; 7(5):623-30. PubMed ID: 16258161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting p53 gene mutation of breast cancer and defining differences between silver staining PCR-SSCP and immunohistochemical staining.
    Ryu JW; Lee MC; Jang WC
    J Korean Med Sci; 2000 Feb; 15(1):73-7. PubMed ID: 10719813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of allelic loss of the P53 gene and tumor grade, stage, and malignant progression in bladder cancer.
    Tsutsumi M; Sugano K; Yamaguchi K; Kakizoe T; Akaza H
    Int J Urol; 1997 Jan; 4(1):74-8. PubMed ID: 9179671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new polymorphic site in intron 2 of TP53 characterizes LOH in human tumors by PCR-SSCP.
    Oliva MR; Saez GT; Latres E; Cordon-Cardo C
    Diagn Mol Pathol; 1995 Mar; 4(1):54-8. PubMed ID: 7735557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma.
    Castresana JS; Rubio MP; Vázquez JJ; Idoate M; Sober AJ; Seizinger BR; Barnhill RL
    Int J Cancer; 1993 Oct; 55(4):562-5. PubMed ID: 8104906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of loss of heterozygosity in tumor DNA samples by PCR.
    Merlo GR; Cropp CS; Callahan R; Takahashi T
    Biotechniques; 1991 Aug; 11(2):166-8, 170-1. PubMed ID: 1931011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of loss of heterozygosity (LOH) at the p53 and Rb suppressor genes in urinary bladder carcinoma].
    Tamada H; Suzuki Y; Tamura G
    Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):722-30. PubMed ID: 7912753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia.
    Nishimura S; Asou N; Suzushima H; Okubo T; Fujimoto T; Osato M; Yamasaki H; Lisha L; Takatsuki K
    Leukemia; 1995 Apr; 9(4):598-604. PubMed ID: 7723391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.